The Valens Company Revenue and Competitors

Kelowna, BC CAN

Location

$169.9M

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • The Valens Company's estimated annual revenue is currently $26.2M per year.(i)
  • The Valens Company's estimated revenue per employee is $270,000
  • The Valens Company's total funding is $169.9M.

Employee Data

  • The Valens Company has 97 Employees.(i)
  • The Valens Company grew their employee count by -19% last year.

The Valens Company's People

NameTitleEmail/Phone
1
VP, Quality and Regulatory Affairs, QAP, RPReveal Email/Phone
2
Director, Human ResourcesReveal Email/Phone
3
Director, Human ResourcesReveal Email/Phone
4
Inventory Control CoordinatorReveal Email/Phone
5
Inventory Control CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$86.4M291-1%N/AN/A
#2
$563.6M6332%$48.6MN/A
#3
$3.1M23-34%$19.3MN/A
#4
$0.2M9-40%$10.8MN/A
#5
$67.1M226-11%N/AN/A
#6
$23M85-12%N/AN/A
#7
$23.8M88-17%$76.8MN/A
#8
$83M2863%$298.1MN/A
#9
$10.4M48-8%N/AN/A
#10
$26.2M97-19%$169.9MN/A
Add Company

What Is The Valens Company?

The Valens Company (TSXV:VGW) (OTC:VGWCF) is a multi-licensed, vertically-integrated cannabis company focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white-label product development. The Valens Company is the largest third-party extraction Company in Canada with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is in the process of becoming European Union (EU) Good Manufacturing Practices (GMP) compliant. Additionally, our subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Science. For more information, please visit the The Valens Company website. The Company?s investor deck can be found specifically at http://thevalenscompany.com/investors/

keywords:N/A

$169.9M

Total Funding

97

Number of Employees

$26.2M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Valens Company News

2022-04-17 - The Valens Company is good for a triple, says Haywood

The company's financial report was headlined by $23.2 million in revenue, which represented a 26 per cent sequential increase while coming out...

2022-04-17 - The Valens Company Secures Agreement for Green Roads ...

The Valens Company's high-quality products are formulated for the medical, health and wellness, and recreational consumer segments, and are...

2022-03-30 - The Valens Company Issues Letter to Shareholders ...

The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company...

2021-11-22 - Pommies Receives Micro-Processing Licence from Health Canada for Greater Toronto Area Facility

KELOWNA, BC, Nov. 22, 2021 /CNW/ - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that Pommies (otherwise known as Southern Cliff Brands) has been issued a micro-processing licenc ...

2021-11-15 - The Valens Company Announces Next Step Towards Nasdaq Listing

KELOWNA, BC, Nov. 15, 2021 /CNW/ - (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that as the next step in its Nasdaq listing process, it will be completing a three for one consolidation (the "Consolidati ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.4M9834%N/A
#2
$20.7M101-2%N/A
#3
$7.5M1138%N/A
#4
$7.5M1152%N/A
#5
$32.7M1213%N/A